Latest Healthcare Research Reports

Category: Veterinary Healthcare

Swine Healthcare Market Outlook Through 2030: Understanding The Growth Opportunity

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Swine Healthcare Market Set To Climb From $3.27 Billion In 2026 To $4.43 Billion By 2030

The swine healthcare market has experienced robust expansion in recent years. Its projected growth trajectory indicates an increase from $3.04 billion in 2025 to $3.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. Historically, this expansion has been driven by factors such as a rise in livestock disease outbreaks, an increase in pork consumption demand, the expansion of commercial pig farming, government initiatives for animal health, and improved availability of veterinary services.

The swine healthcare market is projected to expand significantly over the coming years. This market is set to reach $4.43 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the forecast period include an increasing emphasis on preventing zoonotic diseases, greater investment in precision livestock farming, the growing uptake of advanced vaccines, the expansion of data-driven herd management systems, and the demand for sustainable animal production methods. Key trends anticipated within this period involve the broadening of preventive vaccination initiatives, an increase in herd health management services, a surge in demand for disease diagnostic testing, heightened attention to biosecurity and parasite control, and the integration of nutritional advisory and welfare monitoring services.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=32415&type=smp&name=Swine%20Healthcare%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Swine Healthcare Market Demand Drivers Opening New Revenue Streams

The swine healthcare market is anticipated to expand, driven by the increasing consumption of pork. This consumption signifies the quantity of pork meat consumed by individuals or populations, typically quantified as per person intake over a specific timeframe. An uptick in disposable incomes is contributing to the rise in pork consumption, as it allows consumers to allocate more funds towards diets abundant in animal protein. Inadequate biosecurity is among the elements contributing to an increase in swine diseases. Swine healthcare supports pork consumption by enhancing the well-being and productivity of animals, alongside improving meat quality, thereby guaranteeing a consistent availability of secure and premium pork items to satisfy increasing consumer requirements. As an illustration, in January 2025, Canada Pork International, a promotional body based in Canada, reported that in 2023, Canada’s per capita pork intake grew by 2.10 kg, an increase of 14.40%, reaching 16.72 kg (boneless weight). Consequently, the escalating consumption of pork is fueling the expansion of the swine healthcare market.

Swine Healthcare Market Segment Performance And Emerging Opportunities

The swine healthcare market covered in this report is segmented –

1) By Product Type: Therapeutics, Diagnostics, Nutritional Health, Services

2) By Diseases: Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, Other Diseases

3) By Route of Administration: Injectable, Oral, Intranasal Or Mucosal

4) By Distribution Channel: Direct Sales Or Veterinary Channel, Distributors And Wholesalers, Retail And Online Pharmacies, Service-Integrated Models

5) By End User: Commercial Farms, Smallholder Farms, Research Institutes

Subsegments:

1) By Therapeutics: Vaccines, Antibiotics, Parasiticides

2) By Diagnostics: Polymerase Chain Reaction, Enzyme Linked Immunosorbent Assay, Serology

3) By Nutritional Health: Functional Feed Additives, Probiotics

4) By Services: Herd Health Management, Veterinary Consulting, Reproductive Health

Swine Healthcare Market Trends Powering Strategic Industry Growth

Leading companies in the swine healthcare market are concentrating on developing innovative solutions, such as dual-antigen PCV2 vaccine technology, to provide broader and longer-lasting protection against evolving porcine circovirus strains. These dual-antigen PCV2 vaccines are formulations that incorporate antigens from multiple PCV2 genotypes to strengthen immune coverage and enhance herd health outcomes. For instance, in September 2025, Boehringer Ingelheim, a Germany-based provider of animal health vaccines and therapeutics, launched INGELVAC CIRCOFLEX AD, a next-generation swine vaccine designed to protect pigs against predominant PCV2 strains. The vaccine delivers a fast onset of immunity within about two weeks and provides protection for at least six months, aiding in the reduction of disease impact and the improvement of overall herd performance. It includes a trusted adjuvant to support a robust immune response with a single intramuscular administration, offering producers a convenient and effective tool for porcine circovirus control.

Swine Healthcare Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the swine healthcare market are Boehringer Ingelheim International GmbH, Evonik Operations GmbH, Nutreco N.V., Novonesis A/S, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Alltech Inc., Adisseo S.A., Ceva Santé Animale S.A., Kemin Industries Inc., Neogen Corporation, Genus plc, HIPRA S.A., Dechra Pharmaceuticals plc, Vetoquinol S.A., Indian Immunologicals Limited, Bimeda Inc., Pulike Biological Engineering Inc., Merck Animal Health (MSD), Hester Biosciences Limited, Provimi B.V., Huvepharma NV, IDvet Innovative Diagnostics, Indical Bioscience GmbH, Zoetis Inc.

View The Full Swine Healthcare Market Report:

https://thebusinessresearchcompany.com/report/swine-healthcare-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Swine Healthcare Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the swine healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 21, 2026
Foot And Mouth Disease Diagnostics Market Size Growth: From $1.14 Billion In 2026 To $1.56 Billion By 2030

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Foot And Mouth Disease Diagnostics Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The foot and mouth disease diagnostics market has experienced robust expansion over recent years. This market is projected to expand from $1.06 billion in 2025 to $1.14 billion in 2026, showing a compound annual growth rate (CAGR) of 7.9%. Historically, this expansion has been driven by factors such as recurrent outbreaks of foot and mouth disease, a global increase in livestock populations, the proliferation of veterinary diagnostic laboratories, governmental disease surveillance initiatives, and a heightened understanding of animal health management.

The foot and mouth disease diagnostics market size is projected to experience substantial expansion over the upcoming years. Its valuation is set to reach $1.56 billion by 2030, driven by an 8.1% compound annual growth rate (CAGR). This anticipated growth during the forecast timeframe is propelled by factors such as the increasing need for prompt and swift disease identification, greater investments in veterinary healthcare infrastructure, the evolution of molecular diagnostic technologies, heightened surveillance of cross-border livestock movements, and the creation of portable diagnostic tools. Key developments during this period encompass the rising uptake of real-time PCR diagnostic kits, an escalating need for swift point-of-care testing, broader development of multiplex assays, increased application of lateral flow immunoassays in field environments, and the introduction of highly sensitive ELISA kits.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=61257622&type=smp&name=Foot%20And%20Mouth%20Disease%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Foot And Mouth Disease Diagnostics Market Expansion Drivers: What’s Shaping Future Growth?

The increasing numbers of livestock are projected to drive the expansion of the foot and mouth disease diagnostics market moving forward. Livestock populations refer to the aggregate count of domesticated animals, such as cattle, pigs, and sheep, raised for food production, dairy, or various economic purposes. These animal populations are growing due to a surge in global demand for meat and dairy products, prompting agricultural producers to maintain larger herds. Higher densities of animals elevate the potential for rapid disease transmission, thereby increasing the necessity for prompt detection and continuous surveillance to avert widespread outbreaks and significant economic losses. For instance, in June 2025, according to the Australian Bureau of Statistics, an Australian-based government administration, 30.4 million cattle were on farms as of 30 June 2024, which represented a 1.6% increase compared to June 2023. Thus, the escalating livestock populations are propelling the growth of the foot and mouth disease diagnostics market.

Foot And Mouth Disease Diagnostics Market Segment Analysis Spotlighting Growth Areas

The foot and mouth disease diagnostics market covered in this report is segmented –

1) By Technique: Enzyme-Linked Immunosorbent Assay Kits, Polymerase Chain Reaction Kits, Immunoassays, Chromatography, Other Techniques

2) By Product Type: Kits And Reagents, Instruments, Software, Other Product Types

3) By Animal Type: Cattle, Swine, Sheep And Goats, Other Animal Types

4) By End-User: Veterinary Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay Kits: Indirect Enzyme-Linked Immunosorbent Assay Kits, Sandwich Enzyme-Linked Immunosorbent Assay Kits, Competitive Enzyme-Linked Immunosorbent Assay Kits, Capture Enzyme-Linked Immunosorbent Assay Kits

2) By Polymerase Chain Reaction Kits: Conventional Polymerase Chain Reaction Kits, Real-Time Polymerase Chain Reaction Kits, Multiplex Polymerase Chain Reaction Kits, Reverse Transcription Polymerase Chain Reaction Kits

3) By Immunoassays: Lateral Flow Immunoassays, Radioimmunoassays, Fluorescent Immunoassays, Chemiluminescent Immunoassays

4) By Chromatography: Thin Layer Chromatography, High Performance Liquid Chromatography, Gas Chromatography, Ion Exchange Chromatography

5) By Other Techniques: Western Blotting, Hemagglutination Assays, Agar Gel Immunodiffusion, Flow Cytometry

Foot And Mouth Disease Diagnostics Market Strategic Trends: What Defines The Next Growth Phase?

Leading firms in the foot and mouth disease diagnostics market are prioritizing the creation of novel techniques, including real-time polymerase chain reaction (PCR) assays, to achieve quicker and more precise identification of FMD outbreaks. These real-time PCR assays function as molecular diagnostic tools, capable of detecting and quantifying viral genetic material in real-time, thereby facilitating rapid and accurate identification of foot and mouth disease for efficient outbreak management. As an illustration, BioStone Animal Health LLC, a US-based biotechnology firm, introduced AsurDx Real-Time PCR kits in May 2025 for FMD detection. This represents an advanced molecular diagnostic solution engineered for the swift, sensitive, and multiplex identification of various FMD virus types (A, O, Asia1). These PCR kits include pre-validated reaction mixes, primers, probes, enzymes, and all essential reagents and controls, which ensures quick and dependable setup. Compatible with numerous thermal cyclers, they allow for the quantitative detection of viral genes with significant accuracy and reproducibility. Compared to conventional ELISA tests, these PCR kits deliver swifter and more accurate results, thereby supporting routine diagnostics, outbreak surveillance, and global monitoring initiatives, ultimately enhancing FMD control efforts across the globe.

Foot And Mouth Disease Diagnostics Market Key Players Shaping Industry Direction

Major companies operating in the foot mouth disease diagnostics market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Neogen Corporation, IDvet Inc., Creative Diagnostics Inc., Krishgen Biosystems Pvt. Ltd., AdvaCare Pharma Inc., Biovet Inc., Acro Biotech Inc., Ring Biotechnology Co. Ltd., BioNote Inc., BIO X Diagnostics Inc., GlobalVet Solutions LLC, Median Diagnostics Inc., BioVenic Inc., Avicena LLC, Svanova Biotech AB.

View The Full Foot And Mouth Disease Diagnostics Market Report:

https://thebusinessresearchcompany.com/report/foot-and-mouth-disease-diagnostics-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Foot And Mouth Disease Diagnostics Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the foot and mouth disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the foot and mouth disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 19, 2026
Feline Vaccines Market Reaches $2.53 Billion In 2026: Key Developments Shaping Expansion

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Feline Vaccines Market Set To Climb From $1.91 Billion In 2026 To $2.53 Billion By 2030

The market for feline vaccines has experienced significant growth over recent years. This market is projected to expand from $1.77 billion in 2025 to $1.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. Historically, this growth was driven by factors such as an increase in pet adoption, greater awareness regarding feline health, a rise in infectious diseases, improvements in veterinary care infrastructure, and better adherence to routine vaccinations.

The feline vaccines market is anticipated to experience robust expansion in the coming years. It is projected to reach a valuation of $2.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth throughout the forecast period stems from factors such as a heightened demand for sophisticated feline immunization solutions, an increased emphasis on proactive veterinary care, the growing acceptance of multi-component vaccines, augmented investment in biotechnology for companion animals, and a greater focus on vaccinating early in a cat’s life. Key trends anticipated during this period encompass vaccine breakthroughs driven by technology, progress in platforms for recombinant and DNA vaccines, enhancements in systems for adjuvant and antigen delivery, an uptick in research and development within feline immunology, and novel approaches in needle-free and intranasal vaccination techniques.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=30964&type=smp&name=Feline%20Vaccines%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Feline Vaccines Market Industry Drivers: What’s Behind The Revenue Growth?

The increasing pet cat population is projected to stimulate the expansion of the feline vaccines market moving forward. This term, pet cat population, refers to the rising quantity of domesticated cats residing with households for purposes of companionship, emotional support, and recreation. The growth in the pet cat population is attributable to higher pet adoption rates, coupled with a growing understanding of the mental and emotional advantages associated with pet ownership. Feline vaccines play a vital role in diminishing the occurrence of infectious diseases in cats by conferring immunity against conditions such as feline leukemia virus (FeLV), feline panleukopenia, herpesvirus, and calicivirus, thereby extending their lifespan and enhancing their overall health. For example, in June 2025, information from the American Pet Products Association (APPA), a US-based trade association, showed that cat ownership increased by 23 percent in 2024, with the number of households rising from 40 million in 2023 to 49 million in 2024. Therefore, the expanding pet cat population is a primary catalyst for the growth of the feline vaccines market.

Feline Vaccines Market Segment Outlook: Which Categories Are Growing Fastest?

The feline vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated (Killed) Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

2) By Disease Type: Feline Panleukopenia Virus (FPV), Feline Calicivirus (FCV), Feline Herpesvirus Type 1 (FHV-1), Feline Leukemia Virus (FeLV), Rabies, Feline Immunodeficiency Virus (FIV), Other disease types

3) By Technology: Live Attenuated, Inactivated, Recombinant deoxyribonucleic acid (DNA), Subunit, Toxoi

4) By Route of Administration: Injectable Vaccines, Intranasal Vaccines, Oral Vaccines

5) By End-User: Veterinary Hospitals, Veterinary Clinics, Animal Research Institutes

Subsegments:

1) By Inactivated (Killed) Vaccines: Whole Virus Vaccines, Split Virus Vaccines, Purified Antigen Vaccines

2) By Live Attenuated Vaccines: Modified Live Virus Vaccines, Temperature Sensitive Mutant Vaccines, Attenuated Viral Vector Vaccines

3) By Recombinant Vaccines: Recombinant Viral Vector Vaccines, Recombinant Subunit Vaccines, Deoxyribonucleic Acid (DNA) Based Recombinant Vaccines

#Feline Vaccines Market Growth Trends: What’s Shaping The Future Outlook?

Leading companies within the feline vaccines market are concentrating on creating sophisticated products, including recombinant vector vaccines, with the aim of increasing effectiveness, improving safety, and offering more extensive defense. These recombinant vector vaccines are cutting-edge immunizations where a benign virus carries particular antigens, thereby prompting a powerful and precise immune reaction against the intended pathogen. An example of this is when, in September 2024, MSD Animal Health, a global animal health company based in the US, secured USDA approval for Nobivac NXT FeLV, which is a feline leukemia virus vaccine utilizing its RNA-particle technology platform. This vaccine represents a next-generation, non-adjuvanted recombinant canarypox vector vaccine specifically for feline leukemia virus (FeLV). The vaccine incorporates a patented technology specifically designed to stimulate strong cell-mediated and humoral immunity, consequently offering improved protection against FeLV infection and related ailments. Furthermore, it delivers a low-volume, subcutaneous dose and is recommended for healthy cats 8 weeks of age or older, with the goal of enhancing safety profiles, simplifying administration, and increasing compliance within veterinary practices.

Feline Vaccines Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the feline vaccines market are Merck & Co. Inc., Boehringer Ingelheim Animal Health GmbH, Zoetis Inc., Intas Pharmaceuticals Ltd., Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Virbac SA, Neogen Corporation, Laboratorios HIPRA S.A., Vetoquinol SA, Indian Immunologicals Limited, Jinyu Bio-Technology Co. Ltd., Ourofino Animal Health S.A., Biogénesis Bagó S.A., Biovet Private Limited, Hester Biosciences Limited, Biovet S.A., Durvet Inc., China Animal Husbandry Group Co. Ltd., Biopharma Laboratory, Kyoto Biken Laboratories Inc., Nisseiken Co. Ltd., Liaoning Yikang Biological Co. Ltd., Torigen Pharmaceuticals Inc., Bioveta a.s.

View The Full Feline Vaccines Market Report:

https://thebusinessresearchcompany.com/report/feline-vaccines-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Feline Vaccines Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the feline vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the feline vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 19, 2026
Veterinary Orthopedic Medicine Market Size In 2026: Growth Outlook And Forecast Through 2030

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Veterinary Orthopedic Medicine Market Size And Revenue Outlook Through 2030

The veterinary orthopedic medicine market size has shown robust expansion in recent years. Its valuation is set to rise from $4.03 billion in 2025 to $4.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. The increase observed in the past can be ascribed to a high occurrence of osteoarthritis and joint conditions, an expanding companion animal population, restricted access to advanced orthopedic treatments in earlier periods, a rise in equine and canine athletic pursuits, and the proliferation of veterinary hospitals and clinics.

The veterinary orthopedic medicine market is projected to experience substantial expansion over the upcoming years. This market is set to reach $5.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is largely driven by developments in PRP and stem cell therapies, increased utilization of viscosupplements and NSAIDs, the implementation of sophisticated surgical methods, expanded investment in veterinary orthopedic studies, and heightened understanding of animal mobility and overall well-being. Key trends during this projection period involve the increasing occurrence of musculoskeletal conditions in animals, a growing preference for minimally invasive orthopedic procedures, the rise of stem cell and biologics-based therapeutic options, the broadening of veterinary rehabilitation and physiotherapy offerings, and a strong focus on effective pain management and recuperation following surgery.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=15955&type=smp&name=Veterinary%20Orthopedic%20Medicine%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Orthopedic Medicine Market Growth Drivers: What’s Behind The Acceleration?

A growing occurrence of pet orthopedic diseases is anticipated to propel the future expansion of the veterinary orthopedic medicine market. These conditions refer to ailments affecting the musculoskeletal system of companion animals, particularly dogs and cats. The rising incidence of pet orthopedic diseases can be attributed to factors such as breed predispositions, increasing rates of obesity, and environmental elements like insufficient exercise and poor nutrition. Veterinary orthopedic medicine plays a crucial role in the diagnosis, treatment, and management of these diseases in pets, aiming to alleviate pain, restore mobility, and enhance their overall quality of life. For instance, in July 2024, a report by the Morris Animal Foundation, a US-based non-profit organization, revealed that over 14 million adult dogs in the United States were suffering from osteoarthritis. Additionally, data indicates that approximately 90% of cats over the age of 12 exhibit radiographic signs of osteoarthritis, highlighting the significant prevalence of this condition in aging pets and underscoring a growing demand for increased awareness and advanced treatment options. Therefore, the expanding incidence of pet orthopedic diseases is acting as a key driver for the growth of the veterinary orthopedic medicine market.

Veterinary Orthopedic Medicine Market Segment Outlook: Which Categories Are Growing Fastest?

The veterinary orthopedic medicine market covered in this report is segmented –

1) By Product: Biologics, Viscosupplements, Pharmaceuticals

2) By Animal Type: Canine, Feline, Equine, Cattle, Swine, Other Animal Types

3) By Application: Osteoarthritis, Degenerative Joint Disease, Joint Inflammation Or Pain, Other Applications

4) By End-use: Veterinary Hospitals, Veterinary Clinics, Other End Users

Subsegments:

1) By Biologics: Platelet-Rich Plasma (PRP), Stem Cell Therapy, Bone Marrow Aspirate Concentrate (BMAC), Viscosupplements

2) By Viscosupplements: Hyaluronic Acid, Corticosteroid Injections

3) By Pharmaceuticals: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Antibiotics

Veterinary Orthopedic Medicine Market Trends: What’s Defining The Industry’s Next Phase?

Key companies in veterinary orthopedic medicine are prioritizing investment in advanced technologies. These include 3D printing labs for custom implants, regenerative medicine such as stem cell and platelet-rich plasma (PRP) therapies, and sophisticated imaging techniques like MRI and CT scans tailored for animal patients. A 3D Printing Lab for Pet Orthopedic Surgeries is a specialized facility that uses 3D printing technology to create custom implants, prosthetics, and surgical tools specifically designed for veterinary orthopedic procedures. For instance, in October 2024, VCA Animal Hospitals, a U.S.-based company providing high-quality veterinary care for pets, launched a 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab, utilizing advanced 3D printing technology, aims to improve orthopedic surgeries for pets by producing custom implants and surgical guides specific to each pet’s unique anatomy. Osteoarthritis, affecting 20% of dogs older than one year and 80% of those over eight, often requires surgical intervention. With this personalized approach, VCA seeks to foster faster recovery times and better surgical outcomes, addressing complex orthopedic conditions more effectively than traditional methods.

Veterinary Orthopedic Medicine Market Key Participants And Competitive Landscape

Major companies operating in the veterinary orthopedic medicine market are Zoetis Inc., Elanco Animal Health, Merck Animal Health, Virbac SA, Ceva Santé Animale, Vetoquinol S.A., Bimeda U.S., American Regent, Hyalogic LLC, BioMedtrix LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Veterinary Orthopedic Implants, Integra LifeSciences, Avante Animal Health, DePuy Synthes Vet, KYON AG, Securos Surgical, Arthrex Vet Systems, INNOPLANT Medizintechnik GmbH, VetWelding AG, Scil Animal Care, Intrauma S.p.A., Aysam Veterinary Orthopedics

View The Full Veterinary Orthopedic Medicine Market Report:

https://thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Orthopedic Medicine Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the veterinary orthopedic medicine market in 2025. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026
Veterinary Ophthalmology Equipment Market Trends Supporting 7.6% CAGR Growth Through 2030

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Veterinary Ophthalmology Equipment Market Growth From $0.79 Billion In 2026 To $1.06 Billion By 2030 At A CAGR Of 7.6%

The veterinary ophthalmology equipment market has observed significant growth in recent years. This market is set to expand from $0.73 billion in 2025 to $0.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion has been driven by factors such as the increasing availability of advanced veterinary ophthalmology tools, a rising prevalence of ocular diseases in companion animals, heightened veterinary awareness regarding eye care, the adoption of basic diagnostic and surgical ophthalmic equipment, and the expansion of veterinary hospitals and clinics.

The veterinary ophthalmology equipment market size is projected to experience substantial growth over the coming years. Its value is expected to reach $1.06 billion by 2030, at a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period can be attributed to factors such as the development of advanced digital imaging and OCT systems, increasing investment in minimally invasive surgical tools, a rising demand for species-specific ophthalmic diagnostics, the growth of mobile veterinary ophthalmology services, and the integration of AI and cloud-based platforms for enhanced diagnosis. Major trends anticipated in the forecast period include the rising adoption of optical coherence tomography (OCT) in veterinary practices, an increasing use of digital imaging systems for accurate diagnosis, a growing demand for minimally invasive ophthalmic surgical equipment, the expansion of emergency eye care and vision rehabilitation services, and customized diagnostic solutions designed for different animal species.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=25929&type=smp&name=Veterinary%20Ophthalmology%20Equipment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Ophthalmology Equipment Market Growth Factors Behind Sustained Expansion

Future expansion of the veterinary ophthalmology equipment market is expected to be propelled by the increasing prevalence of pet ownership. Pet ownership refers to the practice of housing and caring for a domestic animal, such as a dog, cat, bird, or other companion, providing necessities like food, shelter, medical attention, and emotional support. The growth in pet ownership primarily stems from the deepening emotional connection between people and animals, as pets are increasingly regarded as companions and integral family members. This rise in pet ownership fuels the need for veterinary ophthalmology equipment by escalating the demand for advanced eye care solutions essential for ensuring the health and well-being of animals. For instance, in 2024, data from Shelter Animals Count, a US-based non-profit organization, indicated that total dog and cat adoptions reached 4,192,443, consisting of 2 million dogs and 2 million cats, representing a slight increase of 0.4%, or 17,153 more adoptions, compared to 2023. Therefore, the growing trend of pet ownership is a significant driver for the veterinary ophthalmology equipment market.

Veterinary Ophthalmology Equipment Market Segment Landscape: Which Areas Lead Development?

The veterinary ophthalmology equipment market covered in this report is segmented –

1) By Type: Diagnostic Devices, Surgical Equipment, Other Types

2) By Technology: Optical Coherence Tomography, Digital Imaging Systems, Fluorescein Angiography, Ultrasound Imaging, Electroretinography

3) By Animal: Equine, Canine, Feline, Bovine

4) By Application: Diagnosis Of Ocular Diseases, Routine Eye Examinations, Surgical Procedures For Eye Disorders, Emergency Eye Care, Vision Rehabilitation

5) By End-User: Animal Hospitals, Veterinary Clinics, Research Institutions, Veterinary Universities, Mobile Veterinary Services

Subsegments:

1) By Diagnostic Devices: Optical Coherence Tomography, Digital Imaging Systems, Fluorescein Angiography, Ultrasound Imaging, Electroretinography

2) By Surgical Equipment: Ophthalmic Microscopes, Phacoemulsification Systems, Microsurgical Instruments, Ophthalmic Lasers, Cryotherapy Units

3) By Other Types: Eye Speculums, Eye Irrigation Systems, Eye Drapes And Surgical Packs, Veterinary Ophthalmic Drugs Administration Tools, Protective Eye Wear For Animals

Veterinary Ophthalmology Equipment Market Industry Trends Fueling Future Revenue Growth

Leading companies in the veterinary ophthalmology equipment market are concentrating on creating technologically advanced solutions, such as ophthalmic surgical devices, to improve the accuracy and results of animal eye surgeries. Ophthalmic surgical devices are specialized instruments utilized by veterinarians for performing precise surgical procedures on animal eyes, including cataract removal or corneal repair. For example, in April 2024, Mount Laurel Veterinary Services LLC, a US-based animal hospital, introduced endolaser cyclophotocoagulation equipment specifically designed for veterinary ophthalmology. This technology incorporates an endoscopic probe that combines illumination, visualization, and laser delivery into one device, allowing veterinarians to treat the eye internally, thereby enhancing precision and minimizing tissue damage. The system supports real-time feedback, is adaptable for various species, and is notably effective for companion animals such as dogs and cats.

Veterinary Ophthalmology Equipment Market Top Companies Driving Competitive Growth

Major companies operating in the veterinary ophthalmology equipment market are Bausch And Lomb Incorporated, HEINE Optotechnik GmbH And Co. KG, Revenio Group Oyj, Tomey Corporation, IRIDEX Corporation, Reichert Inc, GerVetUSA, Eickemeyer, Optomed Plc, United States Intraocular Lens Inc., AJL Ophthalmic S.A., Domes Pharma Inc., iCare Finland Oy, LKC Technologies Inc., AN-VISION GmbH, Biovision Veterinary Endoscopy LLC, Dan Scott And Associates Inc, I-MED Pharma Inc, Kowa American Corporation, Ocularvision Inc.

View The Full Veterinary Ophthalmology Equipment Market Report:

https://thebusinessresearchcompany.com/report/veterinary-ophthalmology-equipment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Ophthalmology Equipment Market Global Footprint: Which Region Leads The Market?

North America was the largest region in the veterinary ophthalmology equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary ophthalmology equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026
Veterinary Oncology Market Forecast Highlights A $0.77 Billion Opportunity For Industry Participants

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Veterinary Oncology Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The veterinary oncology market size has seen rapid growth in recent years. It is anticipated to expand from $0.45 billion in 2025 to $0.5 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The growth observed in the preceding period can be linked to a rising occurrence of cancer in companion animals, increasing recognition of veterinary oncology services, advancements in technology for surgical and radiology equipment, the expansion of veterinary hospitals and specialty clinics, and the adoption of conventional chemotherapy treatments.

The veterinary oncology market is poised for significant expansion in the upcoming years. Its valuation is projected to reach $0.77 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This projected growth is driven by several factors, including an escalating demand for personalized and targeted therapies, the wider adoption of advanced radiology and imaging techniques, the increasing application of immunotherapy and supportive care, ongoing developments in minimally invasive surgical procedures, and the integration of combined chemotherapy and targeted therapy protocols. Key trends during this period will involve the ongoing expansion of personalized and targeted veterinary cancer treatments, further advancements in minimally invasive surgical techniques, the greater embrace of sophisticated radiology and imaging technologies, the evolution of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into comprehensive treatment plans.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=9533&type=smp&name=Veterinary%20Oncology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Oncology Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of cancer in companion animals is anticipated to drive growth in the veterinary oncology market. Cancer is characterized by uncontrolled cell growth spreading within the body, with pet cancer manifesting as physical tumors like swelling. Veterinary oncology specializes in diagnosing and treating cancer in animals, aiming to limit metastasis and disease progression. Consequently, a rise in pet cancer cases will elevate the demand for veterinary oncology services. For example, The Cancer Letter, a US-based publication on cancer research, reported an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Additionally, the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, indicated in November 2023 that approximately 1 in 4 dogs and 1 in 5 cats are expected to develop cancer during their lives. Thus, the rising incidence of cancer in pets is fueling the veterinary oncology market.

Veterinary Oncology Market Segments: Where Is Growth Concentrated?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Veterinary Oncology Market Trends Powering Strategic Industry Growth

Leading companies within the veterinary oncology market are prioritizing the development of neoantigens, which are specific tumor antigens resulting from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific genetic changes within malignant cells. Unlike regular antigens found in healthy tissues, neoantigens are created as a direct consequence of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their potential in developing cancer vaccines and other immunotherapies, with the objective of specifically enhancing the immune response against cancer cells while preserving normal cells.

Veterinary Oncology Market Leading Players And Competitive Positioning

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

View The Full Veterinary Oncology Market Report:

https://thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Oncology Market Regional Split: Which Areas Are Fueling Growth?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026
Veterinary Molecular Diagnostics Market Analysis: How The Industry Is Evolving Toward A $1.11 Billion Future

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Veterinary Molecular Diagnostics Market Growth Potential: How Will Market Size Shift Through 2030?

The veterinary molecular diagnostics market has seen significant expansion over recent years. Its valuation is projected to rise from $0.7 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This historical growth can be linked to several factors including the increasing incidence of infectious and genetic animal diseases, breakthroughs in molecular biology technology, the growing populations of companion and livestock animals, elevated veterinary awareness and training initiatives, and the adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period stems from factors such as increasing demand for swift and precise molecular diagnostics, the widespread adoption of NGS and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of AI-driven diagnostic analysis, and an increasing focus on preventive veterinary care facilitated by molecular testing. Key developments expected in the forecast period encompass the proliferation of PCR and RT-PCR-based diagnostics, the rising uptake of next-generation sequencing (NGS) within veterinary medicine, the creation of multiplex diagnostic kits designed for infectious diseases, the seamless incorporation of molecular diagnostics into standard veterinary care, and the emergence of automated, high-throughput molecular testing solutions.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=20687&type=smp&name=Veterinary%20Molecular%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Molecular Diagnostics Market Growth Backed By Core Demand Fundamentals

The significant occurrence of zoonotic diseases is projected to drive the future growth of the veterinary molecular diagnostics market. These infectious diseases are transferred between animals and humans, and their causes can include bacteria, viruses, parasites, or fungi. Common examples of zoonotic diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis. The widespread nature of zoonotic diseases is influenced by factors like deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of these diseases in animals, which helps prevent their spread to humans. They also improve disease management by enabling the quick and accurate identification of pathogens. For instance, in December 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, stated that in 2024, the reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to rise, indicating a notable ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market.

Veterinary Molecular Diagnostics Market Segment Analysis: What Are The Core Market Categories?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Veterinary Molecular Diagnostics Market Growth Trends Reshaping The Competitive Landscape

Major companies operating in the veterinary molecular diagnostics market are concentrating on automation and scalability in diagnostic technologies, such as high-volume testing machines, to improve diagnostic accuracy, increase testing efficiency, and enable faster detection of diseases in animals. High-volume testing machines are advanced diagnostic devices designed to process large quantities of samples efficiently, enabling rapid and accurate analysis in laboratories or clinical settings, particularly useful for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a cutting-edge molecular diagnostic testing device equipped with quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp. It greatly increases its testing capacity when paired with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Veterinary Molecular Diagnostics Market Competitive Overview And Top Companies

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

View The Full Veterinary Molecular Diagnostics Market Report:

https://thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Molecular Diagnostics Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026
Veterinary Medicine Market Outlook Through 2030: Understanding The Growth Opportunity

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Veterinary Medicine Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The veterinary medicine market has demonstrated significant expansion in recent years. It is projected to increase from $33.21 billion in 2025 to $35.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This historical growth can be attributed to several factors including an expanding livestock population, a rise in pet ownership, the increasing prevalence of animal diseases, the expansion of veterinary hospitals and clinics, and government initiatives aimed at supporting animal health.

The veterinary medicine market size is anticipated to undergo significant growth in the coming years. It is forecast to reach $47.94 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period can be attributed to advancements in veterinary biotechnology, the increasing adoption of digital veterinary solutions, a rising demand for animal vaccines, growth in companion animal healthcare spending, and the expansion of veterinary pharmaceutical manufacturing. Key trends expected in this period include a heightened focus on zoonotic disease control, a growing demand for preventive veterinary care, increased awareness of animal welfare, the broadening of tele-veterinary services, and the integration of evidence-based veterinary practices.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=8027&type=smp&name=Veterinary%20Medicine%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Medicine Market Growth Catalysts And Demand Drivers

A surge in pet ownership is anticipated to fuel the expansion of the veterinary medicine market. Pet owners are individuals who either possess or adopt an animal companion, taking responsibility for their pets’ care and health. The number of pet owners is increasing because more people are seeking companionship and emotional support from pets, leading to a higher rate of pet adoption and ownership. Veterinary medicine assists pet owners by preventing, diagnosing, and treating illnesses in their animals, ensuring their pets remain healthy and live longer, happier lives. For instance, in 2023, according to the Shelter Animals Count, a US-based non-governmental organization, dog adoptions increased by 109,000 compared to 2022, indicating positive growth in adoption rates. However, the total number of dogs adopted in 2023 remains nearly 108,000 lower than in the prior year. Consequently, the expanding pet owner population is driving the veterinary medicine market.

Veterinary Medicine Market Segment Breakdown: Which Categories Lead On Revenue?

The veterinary medicine market covered in this report is segmented –

1) By Product: Drugs, Vaccines, Medical Feed Additives

2) By Animal Type: Companion Animals, Livestock Animals

3) By Route Of Administration: Oral Route, Parental Route, Topical Route

4) By Distribution Channel: Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies

5) By End-Use: Reference Laboratories, Point-Of-Care Testing Or In-House Testing, Veterinary Hospitals And Clinics, Other End-users

Subsegments:

1) By Drugs: Antimicrobials, Anti-inflammatory Drugs, Pain Management Drugs, Hormonal Drugs, Anesthetics

2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Multivalent Vaccines

3) By Medical Feed Additives: Nutritional Supplements, Antimicrobial Feed Additives, Probiotics And Prebiotics, Enzymes, Growth Promoters

Veterinary Medicine Market Trends Shaping Long-Term Demand

Major companies within the veterinary medicine market are introducing novel products, such as ethno-veterinary medicines, to secure a competitive advantage. Ethno-veterinary medicines are formulations derived from Ayurvedic principles and are specifically designed to address animal diseases. For instance, in August 2023, Milma, an India-based dairy company, launched its range of ethno-veterinary medicines. These medicines serve as affordable alternatives to conventional allopathic veterinary drugs. They effectively reduce the financial burden of veterinary expenses for farmers, offering a cost-efficient solution for animal healthcare. Moreover, these preparations represent a simple, economical, and farmer-friendly instrument utilized for both preventive and curative treatments.

Veterinary Medicine Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the veterinary medicine market are Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac, Boehringer Ingelheim International GmbH, Kindred Biosciences Inc., Biogenesis Bago SA, Indian Immunologicals Limited, Neogen Corporation, Hester Biosciences Limited, Phibro Animal Health, Vetoquinol S.A., IDEXX Laboratories Inc., Heska Corporation, Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Bayer Animal Health

View The Full Veterinary Medicine Market Report:

https://thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Medicine Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the veterinary medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the veterinary medicine market report during the forecast period. The regions covered in the veterinary medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026
Veterinary Medical Equipment Market Growth Potential: What The Latest Forecast Reveals

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Veterinary Medical Equipment Market Size Forecast: How Big Could The Market Get By 2030?

The veterinary medical equipment market has demonstrated substantial growth in recent years. It is projected to expand from $3.63 billion in 2025 to $3.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. This historical expansion is primarily due to an expanding companion animal population, heightened awareness regarding animal health, the integration of advanced diagnostic technologies, the proliferation of veterinary hospitals and clinics, and governmental efforts aimed at animal welfare.

The veterinary medical equipment market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach a valuation of $5.24 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This growth during the forecast period is primarily driven by factors such as enhanced technological capabilities in imaging and monitoring, the incorporation of AI into veterinary devices, the broadening scope of telemedicine and remote monitoring services, increased financial commitments to veterinary research and development, and a rise in both pet insurance coverage and healthcare expenditures. Key trends characterizing this period involve the widespread adoption of telemedicine, the development of portable and point-of-care medical devices, the increasing preference for minimally invasive surgical methods, the application of predictive analytics for animal health, and a move towards equipment standardization and modular designs.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=1979&type=smp&name=Veterinary%20Medical%20Equipment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Medical Equipment Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The expansion of pet ownership is anticipated to propel the veterinary medical equipment market. Pet ownership involves individuals or families keeping animals as companions. This increase in pet ownership is primarily driven by rising disposable incomes, greater awareness of the emotional and physical advantages of pet companionship, and evolving societal norms that increasingly view pets as integral family members. Veterinary medical equipment, such as home diagnostic kits and portable monitoring devices, empowers pet owners to better manage their pets’ health, facilitating early illness detection and ensuring timely veterinary care. For instance, in October 2024, according to the American Veterinary Medical Association, a nonprofit professional association, the total number of dog-owning households in the U.S. is projected to increase by 59.8 million in 2024, representing 45.5% of all U.S. households, and the number of cat-owning households has increased by 42.1 million in 2024, which is 32.1% of all U.S. households. Therefore, the growth in pet ownership is a significant driver for the veterinary medical equipment market.

Veterinary Medical Equipment Market Segmentation: How Does The Market Break Down By Category?

The veterinary medical equipment market covered in this report is segmented –

1) By Type: Veterinary Diagnostic Equipment, Veterinary Anesthesia Equipment, Veterinary Patient Monitoring Equipment, Other Types

2) By Component Type: Instruments Or Equipment, Disposables

3) By Animal Type: Small Companion Animals, Large Animals, Other Animals

4) By End User: Veterinary Hospitals, Veterinary Clinics, Research Institutes

Subsegments:

1) By Veterinary Diagnostic Equipment: X-Ray Systems, Ultrasound Systems, Magnetic Resonance Imaging (Mri) Systems, Computed Tomography (Ct) Scanners, Endoscopy Devices

2) By Veterinary Anesthesia Equipment: Anesthesia Machines, Ventilators, Vaporizers, Gas Delivery Management Systems, Waste Gas Management Systems

3) By Veterinary Patient Monitoring Equipment: ECG Monitors, Blood Pressure Monitors, Respiratory Monitors, Temperature Monitors, Multiparameter Monitors

4) By Other Types: Surgical Instruments, Infusion Pumps, Dental Equipment, Laboratory Equipment

Veterinary Medical Equipment Market Innovation Trends Shaping Future Development

Leading companies in the animal services market are concentrating on technological advancements like the Magnifico Vet MRI System to sustain their market position. The Magnifico Vet MRI System is an innovative imaging solution that provides effective diagnostics in various veterinary hospitals. For example, in January 2023, Esaote North America, Inc., a US-based animal health technology company, launched the Magnifico Vet MRI System, which is engineered for animals of different sizes. This eco-conscious Magnifico Vet utilizes sustainable green permanent-magnet technology, operating without the necessity for cryogens and consuming significantly less power compared to superconducting systems. It signifies a remarkable accomplishment in functional design, ready to deliver exceptional diagnostic image quality.

Veterinary Medical Equipment Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the veterinary medical equipment market are Covetrus Inc., IDEXX Laboratories Inc., Integra LifeSciences Corporation, Mindray Medical International Limited, Midmark Corporation, Smiths Group plc, Carestream Health, Agfa-Gevaert Group, Nonin Medical, B. Braun Vet Care GmbH, Risol International Industrial Co. Limited, Guangzhou Medsinglong Import & Export Co. Ltd., Applied Bio Diagnostics Private Limited, Zoetis, Elanco, Merck Co. Inc, Vetpak, Agilis Ltd, Eickemeyer, Vetlabsupplies, Burtons, Dixion, Vic Group, Vetmarket, Draminski, Gervetusa Veterinary Surgical Instruments, X-Cel X-Ray Corp, Surgitel, Ceba, Centrovet, Hoppner Vet, Instituto Veterinario Uruguay S.A

View The Full Veterinary Medical Equipment Market Report:

https://thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Medical Equipment Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the veterinary medical equipment market in 2025. Asia-Pacific was the second-largest region in the veterinary medical equipment market. The regions covered in the veterinary medical equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026
Veterinary Laboratory Testing Services Market Growth Outlook: Why Analysts Expect Continued Expansion

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Veterinary Laboratory Testing Services Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The veterinary laboratory testing services market size has experienced significant expansion in recent years. It is anticipated to increase from $25.94 billion in 2025 to $27.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. The growth observed in the past can be ascribed to elements such as the growing acceptance of veterinary laboratory testing services, the development of companion animal healthcare, improvements in hematology and biochemistry testing, heightened understanding of zoonotic diseases, and the constrained accessibility of integrated diagnostic platforms.

The veterinary laboratory testing services market is poised for significant expansion over the coming years, projected to reach $38.14 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth can be largely attributed to several factors, including the increasing availability of molecular and immunodiagnostic services, a surge in the embrace of rapid and point-of-care testing, the merging of multi-technology laboratory platforms, a rise in animal preventive health initiatives, and the implementation of cloud-based data management and analytics systems. Key developments during this forecast period are expected to encompass the widespread use of molecular diagnostics, the emergence of rapid point-of-care testing solutions, sophisticated immunodiagnostic methods, the incorporation of diverse laboratory technologies, and comprehensive preventive health checks for both livestock and household pets.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=2543&type=smp&name=Veterinary%20Laboratory%20Testing%20Services%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Laboratory Testing Services Market Growth Momentum: What Factors Are Shaping Demand?

The increasing pet ownership is projected to boost the growth of the veterinary laboratory testing services market in the coming years. Pet ownership involves the responsibility of caring for a domesticated animal, such as a cat, dog, bird, fish, or other small creatures, by meeting their requirements, which include providing sustenance, shelter, exercise, and healthcare. The percentage of pet owners worldwide is continually increasing, which has escalated the need for veterinary diagnostics. Pet owners are becoming more aware of the importance of regular check-ups and preventative care for their dogs, which has heightened the demand for veterinary laboratory testing services. For instance, in June 2025, according to the Petfood Industry, a US-based resource for pet food & treat manufacturers, a record 94 million U.S. households owned at least one pet, up from 82 million in 2023, showcasing a substantial increase in pet ownership that drives demand for veterinary services including diagnostic testing. Consequently, the expanding pet ownership is a key factor propelling the veterinary laboratory testing services market.

Veterinary Laboratory Testing Services Market Segment Trends And Revenue Contributors

The veterinary laboratory testing services market covered in this report is segmented –

1) By Technology: Clinical Biochemistry, Immunodiagnostics, Hematology, Molecular Diagnostics, Other Technologies

2) By Animal Type: Companion Animals, Livestock

3) By End User: Veterinary Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, In-House Testing, Other End-Users

Subsegments:

1) By Clinical Biochemistry: Blood Chemistry Analysis, Urinalysis, Electrolyte Analysis, Glucose Monitoring, Immunodiagnostics

2) By Immunodiagnostics: Enzyme-Linked Immunosorbent Assay (ELISA), Lateral Flow Assays (LFA), Radioimmunoassay, Rapid Tests

3) By Hematology: Complete Blood Count (CBC), Blood Smear Examination, Coagulation Tests, Hemoglobin Analysis

4) By Molecular Diagnostics: Polymerase Chain Reaction (PCR), Nucleic Acid Sequencing, Microarrays, Hybridization

5) By Other Technologies: Cytology, Microbiology, Urinalysis

Veterinary Laboratory Testing Services Market Trends Redefining Industry Growth

Major companies in the veterinary laboratory testing services market are focusing on developing innovative, integrated diagnostic solutions, such as comprehensive end-to-end veterinary diagnostics platforms. This initiative is driven by the increasing demand for faster, more accurate testing, earlier disease detection, and streamlined clinical workflows, all of which are fueled by rising pet ownership and a greater emphasis on preventive veterinary care. A comprehensive end-to-end veterinary diagnostics platform is defined as an integrated system that combines reference laboratory testing, in-house diagnostic instruments, imaging, digital pathology, and data analytics into a single workflow. This structure helps veterinarians deliver quicker, more precise diagnoses, simplify clinical decision-making, and improve patient outcomes when compared with fragmented or standalone diagnostic services. As an illustration, in November 2023, Antech, a US-based veterinary diagnostics company and part of Mars Science & Diagnostics, launched its first comprehensive veterinary diagnostics offering in the UK, supported by a new state-of-the-art reference laboratory in Warwick. This offering integrates reference laboratory services with in-house diagnostics, advanced imaging solutions, telemedicine, and innovative technologies like a DNA-based gastrointestinal parasite screening solution; a rapid imaging system that provides diagnostic results in under ten minutes; and an upcoming nucleosome-based test designed to screen and monitor canine cancer. This all-encompassing approach enhances diagnostic accuracy, reduces the time to diagnosis, and supports veterinarians with flexible, data-driven testing solutions across a wide array of clinical applications.

Veterinary Laboratory Testing Services Market Company Landscape And Competitive Strategy

Major companies operating in the veterinary laboratory testing services market are IDEXX Laboratories, Mars Incorporated, Zoetis Inc, CVS Group PLC, Heska Corporation, Gribbles Veterinary, Neogen Corporation, GD Animal Health, Greencross Limited, ProtaTek International, Inc, Vetserv India, Pathvets, VETLAB, MSD Animal Health (Merck), Boehringer Ingelheim, Bayer Healthcare, Vetoquinol SA, Ceva Sante Animale, Frantz Cappe, Clinique Veterinaire Metivet, Alizee Vet Clinic, Cristina Cardone, Abbey House Veterinary Hospital, Aberdeen Veterinary Referrals, Abington Park Vets, Acorn House Veterinary Hospital, Alma Veterinary Hospital, Anderson Moores Veterinary Specialists, Animal Trust Vets CIC Bolton, Animed Veterinary Hospital & Equine Unit, Draminski, Agnieszka Jakubowska Equi Serwis Gabinet Weterynaryjny, BHH MIKROMED SP. Z O.O, BWF Technologies Sp. Z O.O, Bioticapharma, Veterinary Purchasing Company Limited, Associated Vet Purchasing, Acell, Addison Biological Laboratory Inc, Colorado Serum Company, Elanco Animal Health, Icare Tonovet, Kindred Biosciences, Merck Animal Health, Norbrook Inc, J.A Saude Animal, Eurofins Sao Paulo Brazil, Vaxxinova, Gulf Veterinary Services Company, Mansour Al Mosaid Group, Karaman Veterinary Medicines Co LLC, IFT ANIMAL HEALTH LLC, Bupo Animal Health, Virbac SA, Animal Care Services Konsult Nigeria Ltd, Egavet, Al Walaa Co, Alliance Pharma EG, Cowtribe

View The Full Veterinary Laboratory Testing Services Market Report:

https://thebusinessresearchcompany.com/report/veterinary-laboratory-testing-services-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Laboratory Testing Services Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the veterinary laboratory testing market in 2025. Asia-Pacific was the second-largest region in the global veterinary laboratory testing market report. The regions covered in the veterinary laboratory testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

October 9, 2026